Speed of New Regs Slows Drug Development in India
By Mari Serebrov
Tuesday, July 16, 2013
The brakes are on India's clinical trials industry as the country implements stiffer regulations in response to outcries that its citizens are being treated like human guinea pigs.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.